nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—SLC22A2—Metformin—polycystic ovary syndrome	0.49	0.535	CbGbCtD
Tubocurarine—SLC22A1—Metformin—polycystic ovary syndrome	0.425	0.465	CbGbCtD
Tubocurarine—ACHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000167	0.00196	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000167	0.00196	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000164	0.00192	CbGpPWpGaD
Tubocurarine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00016	0.00188	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000159	0.00187	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000156	0.00183	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000156	0.00183	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000153	0.0018	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000153	0.0018	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SUOX—polycystic ovary syndrome	0.000153	0.0018	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000153	0.00179	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000151	0.00177	CbGpPWpGaD
Tubocurarine—ACHE—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.000145	0.0017	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—DLG4—polycystic ovary syndrome	0.000145	0.0017	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000143	0.00169	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000142	0.00167	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000141	0.00166	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000141	0.00166	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00014	0.00164	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000139	0.00163	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000138	0.00162	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000136	0.0016	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—DLG4—polycystic ovary syndrome	0.000135	0.00159	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000135	0.00158	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000134	0.00157	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000133	0.00156	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000133	0.00156	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00013	0.00153	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00013	0.00152	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000128	0.00151	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000128	0.0015	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000125	0.00147	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000125	0.00147	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000125	0.00147	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000125	0.00146	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000124	0.00146	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000123	0.00145	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000123	0.00145	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000123	0.00144	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000122	0.00143	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SUOX—polycystic ovary syndrome	0.000122	0.00143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000121	0.00142	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000121	0.00142	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000119	0.0014	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000118	0.00139	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000118	0.00139	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000116	0.00137	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000116	0.00137	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000115	0.00136	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000114	0.00134	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000113	0.00133	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SUOX—polycystic ovary syndrome	0.000113	0.00133	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000113	0.00133	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000111	0.00131	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.000111	0.00131	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00011	0.0013	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000109	0.00129	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000107	0.00126	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000107	0.00126	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000107	0.00126	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000105	0.00124	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000104	0.00123	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000102	0.0012	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000101	0.00119	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0001	0.00118	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	9.73e-05	0.00114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TEAD2—polycystic ovary syndrome	9.62e-05	0.00113	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKR1C2—polycystic ovary syndrome	9.62e-05	0.00113	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SRD5A1—polycystic ovary syndrome	9.59e-05	0.00113	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	9.54e-05	0.00112	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	9.48e-05	0.00111	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	9.47e-05	0.00111	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—STAR—polycystic ovary syndrome	9.15e-05	0.00108	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	9.09e-05	0.00107	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.05e-05	0.00106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	8.97e-05	0.00105	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	8.97e-05	0.00105	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—ACE—polycystic ovary syndrome	8.8e-05	0.00103	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	8.78e-05	0.00103	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	8.68e-05	0.00102	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	8.64e-05	0.00102	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	8.61e-05	0.00101	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	8.57e-05	0.00101	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	8.46e-05	0.000994	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	8.18e-05	0.000962	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—HMMR—polycystic ovary syndrome	8.16e-05	0.000959	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	8.06e-05	0.000948	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.99e-05	0.000939	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.97e-05	0.000937	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	7.9e-05	0.000929	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.84e-05	0.000922	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—HSD3B1—polycystic ovary syndrome	7.78e-05	0.000915	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.69e-05	0.000904	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	7.64e-05	0.000899	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	7.61e-05	0.000894	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	7.59e-05	0.000892	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	7.52e-05	0.000883	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	7.51e-05	0.000883	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	7.49e-05	0.000881	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.43e-05	0.000873	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	7.34e-05	0.000863	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	7.29e-05	0.000857	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.29e-05	0.000857	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.29e-05	0.000857	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	7.27e-05	0.000854	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	7.17e-05	0.000843	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	7.12e-05	0.000838	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—LHB—polycystic ovary syndrome	7.1e-05	0.000834	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	7.04e-05	0.000828	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—HSD3B2—polycystic ovary syndrome	6.94e-05	0.000815	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.91e-05	0.000812	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.86e-05	0.000806	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	6.82e-05	0.000802	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	6.8e-05	0.000799	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.79e-05	0.000799	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.74e-05	0.000792	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKR1C1—polycystic ovary syndrome	6.72e-05	0.00079	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.72e-05	0.00079	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.67e-05	0.000784	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	6.53e-05	0.000768	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	6.5e-05	0.000764	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	6.39e-05	0.000752	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.33e-05	0.000744	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.33e-05	0.000744	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	6.2e-05	0.000729	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SULT2A1—polycystic ovary syndrome	6.18e-05	0.000727	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.12e-05	0.000719	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	6.1e-05	0.000717	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	6.06e-05	0.000712	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—RRM2—polycystic ovary syndrome	5.99e-05	0.000704	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.96e-05	0.0007	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.92e-05	0.000696	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	5.78e-05	0.000679	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—YAP1—polycystic ovary syndrome	5.77e-05	0.000678	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.75e-05	0.000676	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.7e-05	0.00067	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	5.65e-05	0.000665	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.59e-05	0.000657	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NAMPT—polycystic ovary syndrome	5.55e-05	0.000652	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	5.53e-05	0.00065	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.51e-05	0.000648	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP11A1—polycystic ovary syndrome	5.48e-05	0.000644	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—LEP—polycystic ovary syndrome	5.47e-05	0.000643	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	5.45e-05	0.000641	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.44e-05	0.000639	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	5.35e-05	0.000629	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	5.27e-05	0.00062	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKR1C3—polycystic ovary syndrome	5.17e-05	0.000608	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	5.15e-05	0.000606	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP17A1—polycystic ovary syndrome	5.09e-05	0.000598	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.09e-05	0.000598	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	4.99e-05	0.000586	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.96e-05	0.000583	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.93e-05	0.000579	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	4.77e-05	0.000561	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—POMC—polycystic ovary syndrome	4.7e-05	0.000552	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—INS—polycystic ovary syndrome	4.67e-05	0.000549	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	4.63e-05	0.000545	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	4.6e-05	0.000541	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	4.59e-05	0.00054	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	4.54e-05	0.000533	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.52e-05	0.000531	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	4.52e-05	0.000531	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.51e-05	0.00053	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	4.45e-05	0.000523	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	4.42e-05	0.000519	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TH—polycystic ovary syndrome	4.41e-05	0.000518	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.36e-05	0.000513	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.36e-05	0.000512	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	4.29e-05	0.000504	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC2A4—polycystic ovary syndrome	4.29e-05	0.000504	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.24e-05	0.000498	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	4.13e-05	0.000485	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.12e-05	0.000484	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	4.12e-05	0.000484	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.11e-05	0.000483	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.08e-05	0.00048	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	4.07e-05	0.000478	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.06e-05	0.000477	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	4.03e-05	0.000474	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	4.03e-05	0.000474	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.94e-05	0.000463	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.84e-05	0.000451	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.82e-05	0.000449	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.81e-05	0.000448	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.78e-05	0.000444	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	3.78e-05	0.000444	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.73e-05	0.000438	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.6e-05	0.000424	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GNAS—polycystic ovary syndrome	3.6e-05	0.000423	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	3.54e-05	0.000416	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	3.51e-05	0.000413	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	3.51e-05	0.000413	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.46e-05	0.000406	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	3.43e-05	0.000403	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.41e-05	0.000401	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.28e-05	0.000385	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	3.27e-05	0.000385	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	3.25e-05	0.000382	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.23e-05	0.00038	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.21e-05	0.000377	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.18e-05	0.000374	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	3.09e-05	0.000363	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	3.03e-05	0.000356	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.99e-05	0.000352	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.94e-05	0.000345	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.89e-05	0.00034	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	2.87e-05	0.000337	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	2.86e-05	0.000337	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	2.73e-05	0.000321	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	2.67e-05	0.000314	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.66e-05	0.000313	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.66e-05	0.000313	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.59e-05	0.000304	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.56e-05	0.000301	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	2.54e-05	0.000299	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.54e-05	0.000298	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.48e-05	0.000291	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.46e-05	0.00029	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPARG—polycystic ovary syndrome	2.46e-05	0.000289	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—POMC—polycystic ovary syndrome	2.42e-05	0.000285	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	2.41e-05	0.000284	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.41e-05	0.000283	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—INS—polycystic ovary syndrome	2.41e-05	0.000283	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.34e-05	0.000275	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.33e-05	0.000274	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	2.32e-05	0.000273	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	2.25e-05	0.000264	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.24e-05	0.000263	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.2e-05	0.000259	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.04e-05	0.00024	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.96e-05	0.00023	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.95e-05	0.000229	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.93e-05	0.000227	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.92e-05	0.000226	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.91e-05	0.000225	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	1.82e-05	0.000214	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	1.8e-05	0.000211	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	1.79e-05	0.00021	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.64e-05	0.000192	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	1.6e-05	0.000188	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.43e-05	0.000168	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	1.38e-05	0.000162	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	1.37e-05	0.000161	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.32e-05	0.000156	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.32e-05	0.000155	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.26e-05	0.000148	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.01e-05	0.000119	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.64e-06	0.000102	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	5.98e-06	7.03e-05	CbGpPWpGaD
